Alpine Global Management’s Nautilus Biotechnolgy NAUT Stock Holding History

Alpine Global Management’s Portfolio NAUT Stock Details NAUT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-26,477	Closed	-$56K	–	519
2022 Q3	$56K	Hold	26,477	–	–	0.01%	137
2022 Q2	$71K	Hold	26,477	–	–	0.02%	157
2022 Q1	$115K	Hold	26,477	–	–	0.03%	277
2021 Q4	$137K	Hold	26,477	–	–	0.02%	518
2021 Q3	$163K	Sell	26,477 -117,647	-82%	-$937K	0.04%	228
2021 Q2	$1.46M	Buy	+144,124	New	+$1.56M	0.2%	92

Other funds holding NAUT

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return

MVG

Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CFM

Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

Tikvah Management Charlotte, North Carolina $329M AUM 64.12% 1-Year Est. Return

ACI

Amazon.com Inc Seattle, Washington $4.42B AUM 22.6% 1-Year Est. Return

ArchPoint Investors Coral Gables, Florida $473M AUM 49.24% 1-Year Est. Return

Alpine Global Management's NAUT Position: Q4 2022 in Review

Alpine Global Management sold out of Nautilus Biotechnolgy (NAUT) in Q4 2022, closing a stake of 26,477 shares — an estimated $56K sold.

Alpine Global Management first reported a position in NAUT in Q2 2021 and held it in 6 quarters. The position peaked at $1.46M in Q2 2021. 81 funds tracked by Wall St. Rank hold NAUT as of Q4 2022.

Alpine Global Management reported no remaining Nautilus Biotechnolgy position as of Q4 2022 after selling out during the quarter.
Alpine Global Management sold 26,477 Nautilus Biotechnolgy shares in Q4 2022, an estimated $56K.
Alpine Global Management first reported a position in Nautilus Biotechnolgy in Q2 2021 and held it in 6 quarters.
Alpine Global Management's Nautilus Biotechnolgy position peaked at $1.46M in Q2 2021.
81 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q4 2022.

Based on Alpine Global Management's 13F filing for Q4 2022, filed 14 Feb 2023.